European Healthtech startup funding raised during H1 2022.
In H1 2022, 325 European Healthtech companies raised a combined €4.6B across 329 funding rounds, up 17.7% versus H1 2021. France led by capital raised, and Bpifrance was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Doctolib | Debt | Mar 2022 | €500M |
| Patient21 | Other | Jan 2022 | €126M |
| Leyden Labs | Series B | Jan 2022 | €124M |
| Imcheck Therapeutics | Other | Jun 2022 |
29 exits · €7.7B disclosed.
| Pharma Intelligence | Acquisition | Feb 2022 | €2.3B |
| Norgine | Acquisition | Jun 2022 | €1.8B |
| Zogenix | Acquisition | Jan 2022 | €1.7B |
| SPT Labtech | Acquisition | Jun 2022 | €757M |
| ReViral | Acquisition | Apr 2022 | €483M |
| Normax | IPO | Jun 2022 | €300M |
| €96M |
| MindMaze | Other | Feb 2022 | €92M |
| OMass Therapeutics | Series B | Apr 2022 | €90M |
| Ori Biotech | Series B | Jan 2022 | €88M |
| Padoa | Other | Feb 2022 | €80M |
| Precirix | Series B | Mar 2022 | €80M |
| DistalMotion | Series D+ | Jan 2022 | €80M |
| Proximie | Series C | Jun 2022 | €77M |
| Ambagon Therapeutics | Series A | Jan 2022 | €75M |
| Owkin | Series B | Jun 2022 | €74M |
| Diabeloop | Other | Jun 2022 | €70M |
| Immunos Therapeutics | Series B | Jun 2022 | €68M |
